<html xmlns="http://www.w3.org/1999/xhtml" lang="en-US"><head><meta charset="UTF-8"><meta http-equiv='content-language' content='en-us'/><title>SDLRC - Codified Law 13-33A-15 - Nasal glucagon--Authorized employees--Training--Documentation.</title><meta name="Generator" content="PowerTools for Open XML"><style>span { white-space: pre-wrap; } p.sc498d7253dc344c39d0b27007c10cbe6Normal { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sc498d7253dc344c39d0b27007c10cbe6SENU { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sc498d7253dc344c39d0b27007c10cbe6CL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } p.sc498d7253dc344c39d0b27007c10cbe6Statute { text-indent: 0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sc498d7253dc344c39d0b27007c10cbe6StatuteNumber1 { margin-left: 0.75in; text-indent: -0.50in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-right: 0; margin-bottom: .001pt; } span.sc498d7253dc344c39d0b27007c10cbe6000000 { font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } p.sc498d7253dc344c39d0b27007c10cbe6NoIndent { text-indent: 0.00in; text-align: justify; font-family: 'Times New Roman', 'serif'; font-size: 12pt; line-height: 108%; margin-top: 0; margin-left: 0; margin-right: 0; margin-bottom: .001pt; } span.sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont-000001 { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: bold; margin: 0; padding: 0; } span.sc498d7253dc344c39d0b27007c10cbe6SCL { font-family: 'Times New Roman', 'serif'; font-size: 12pt; font-style: normal; font-weight: normal; margin: 0; padding: 0; } body { text-decoration-skip-ink: none; } </style><meta name="viewport" content="width=device-width, initial-scale=1"><meta name="twitter:card" content="summary"><meta property="og:title" content="SD 13-33A-15 - Nasal glucagon--Authorized employees--Training--Documentation."><meta property="og:description" content="SDLRC Codified Law 13-33A-15 - Nasal glucagon--Authorized employees--Training--Documentation."><meta property="og:type" content="website"><meta property="og:url" content="https://sdlegislature.gov/Statutes/13-33A-15"><meta property="og:image" content="https://lawmakerdocuments.blob.core.usgovcloudapi.net/photos/logoshape.webp"><meta property="og:site_name" content="South Dakota Legislature"></head><body><div><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6Normal"><a href="https://sdlegislature.gov/Statutes?Statute=13-33A-15" rel="noopener"><span class="sc498d7253dc344c39d0b27007c10cbe6SENU">13-33A-15</span></a><span xml:space="preserve" class="sc498d7253dc344c39d0b27007c10cbe6SENU">. </span><span class="sc498d7253dc344c39d0b27007c10cbe6CL">Nasal glucagon--Authorized employees--Training--Documentation.</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6Statute"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">The board of a school district or the governing board of a nonpublic school may authorize an employee to administer nasal glucagon to a student if the employee completes training, provided by a licensed health care provider, that addresses:</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6StatuteNumber1"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">(1)    Recognizing the symptoms of severe hypoglycemia;</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6StatuteNumber1"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">(2)    The procedure for administering nasal glucagon;</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6StatuteNumber1"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">(3)    Emergency care for an individual experiencing severe hypoglycemia, including care after administering nasal glucagon; and</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6StatuteNumber1"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">(4)    The storage, maintenance, and disposal of nasal glucagon.</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6Statute"><span xml:space="preserve" class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">The school district or the nonpublic school must maintain documentation of each employee who completes the training and who is authorized to administer nasal glucagon in accordance with §§ </span><a href="https://sdlegislature.gov/Statutes?Statute=13-33A-12" rel="noopener"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">13-33A-12</span></a><span xml:space="preserve" class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont"> to </span><a href="https://sdlegislature.gov/Statutes?Statute=13-33A-16" rel="noopener"><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">13-33A-16</span></a><span class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont">, inclusive.</span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6Normal"><span xml:space="preserve" class="sc498d7253dc344c39d0b27007c10cbe6000000"> </span></p><p dir="ltr" class="sc498d7253dc344c39d0b27007c10cbe6NoIndent"><span xml:space="preserve" class="sc498d7253dc344c39d0b27007c10cbe6DefaultParagraphFont-000001">Source: </span><span class="sc498d7253dc344c39d0b27007c10cbe6SCL">SL 2024, ch 57, § 4.</span></p></div></body></html>